Sage Journals: Discover world-class research

Abstract

Extended-release medications for opioid use disorder (XR-MOUD) with young adults have shown promise to increase treatment adherence, though dropout remains high. Recovery capital factors like relationship quality and recovery attitudes may influence treatment outcomes in young adults with OUD. This study examined the relationship between initial opioid use, recovery capital, and treatment outcomes among 52 young adults (11.5% female) receiving MOUD in a novel treatment program. Recovery capital factors were self-reported pre- and post-treatment, and treatment outcomes (opioid use days and MOUD dosages) were assessed via self-report and urinary screens. Recovery attitudes buffered the association between baseline opioid use and days used during the study and were found to change non-uniformly longitudinally. Moreover, more frequent negative relationship events buffered the association between initial opioid use severity and days used. This study adds novel information to the literature regarding recovery attitudes and factors involved in young adult opioid use treatment.

Keywords

opioid use disorder medication-assisted treatment recovery attitudes relationship quality young adults substance use recovery capital

Get full access to this article

View all access options for this article.

References

Ali

Fisher

D. A.

Miller

T. R.

Lawrence

B. A.

Spicer

R. S.

Swedler

D. I.

Allison

(2019). Trends in drug poisoning deaths among adolescents and young adults in the United States, 2006–2015. Journal of Studies on Alcohol and Drugs, 80(2), 201–210. https://doi.org/10.15288/jsad.2019.80.201

Alinsky

R. H.

Zima

B. T.

Rodean

Matson

P. A.

Larochelle

M. R.

Adger

Bagley

S. M.

Hadland

S. E.

(2020). Receipt of addiction treatment after opioid overdose among Medicaid-enrolled adolescents and young adults. JAMA Pediatrics, 174(3), e195183. https://doi.org/10.1001/jamapediatrics.2019.5183

American Psychiatric Association . (2013). Diagnostic and statistical manual of mental disorders (5th ed.). APA. https://doi.org/10.1176/appi.books.9780890425596

Ariss

Fairbairn

C. E.

(2020). The effect of significant other involvement in treatment for substance use disorders: A meta-analysis. Journal of Consulting and Clinical Psychology, 88(6), 526–540. https://doi.org/10.1037/ccp0000495

Barnes

(2019). A regression study of factors that predict recovery attitudes in opioid users [Doctoral dissertation, Capella University]. ProQuest Dissertations & Theses Global. https://www.proquest.com/pqdtglobal/docview/2246464498/abstract/23163E4F5E20496APQ/18

Benishek

Dugosh

Faranda-Diedrich

Kirby

(2006). Development of the Significant Other Survey: An interview for family members of substance users. American Journal of Family Therapy, 34(1), 33–46. https://doi.org/10.1080/01926180500301378

Benishek

L. A.

Carter

Clements

N. T.

Allen

Salber

K. E.

Dugosh

Kirby

K. C.

(2012). Psychometric assessment of a self-administered version of the significant other survey. Psychology of Addictive Behaviors: Journal of the Society of Psychologists in Addictive Behaviors, 26(4), 986–993. https://doi.org/10.1037/a0030378

Benishek

L. A.

Kirby

K. C.

Dugosh

K. L.

(2011). Prevalence and frequency of problems of concerned family members with a substance-using loved one. The American Journal of Drug and Alcohol Abuse, 37(2), 82–88. https://doi.org/10.3109/00952990.2010.540276

Best

Gow

Knox

Taylor

Groshkova

White

(2012). Mapping the recovery stories of drinkers and drug users in Glasgow: Quality of life and its associations with measures of recovery capital. Drug and Alcohol Review, 31(3), 334–341. https://doi.org/10.1111/j.1465-3362.2011.00321.x

10.

Best

Gow

Taylor

Knox

White

(2011). Recovery from heroin or alcohol dependence: A qualitative account of the recovery experience in glasgow. Journal of Drug Issues, 41(3), 359–377. https://doi.org/10.1177/002204261104100303

11.

Borodovsky

J. T.

Levy

Fishman

Marsch

L. A.

(2018). Buprenorphine treatment for adolescents and young adults with opioid use disorders: A narrative review. Journal of Addiction Medicine, 12(3), 170–183. https://doi.org/10.1097/ADM.0000000000000388

12.

Brorson

H. H.

Ajo Arnevik

Rand-Hendriksen

Duckert

(2013). Drop-out from addiction treatment: A systematic review of risk factors. Clinical Psychology Review, 33(8), 1010–1024. https://doi.org/10.1016/j.cpr.2013.07.007

13.

Butler

Bauld

(2005). The parents’ experience: Coping with drug use in the family. Drugs: Education, Prevention & Policy, 12(1), 35–45. https://doi.org/10.1080/0968763042000275308

14.

Cale

E. L.

Deane

F. P.

Kelly

P. J.

Lyons

G. C. B.

(2015). Psychometric properties of the Recovery Assessment Scale in a sample with substance use disorder. Addiction Research and Theory, 23(1), 71–80. https://doi.org/10.3109/16066359.2014.938061

15.

Campbell-Orde

Chamberlin

Carpenter

Leff

(2005). Measuring the promise: A compendium of recovery measures Volume II. Retrieved December 28, 2021, from. https://www.hsri.org//publication/measuring-the-promise-a-compendium-of-recovery-measures-volume-ii

16.

Chalana

Kundal

Gupta

Malhari

A. S.

(2016). Predictors of relapse after inpatient opioid detoxification during 1-year follow-up. Journal of Addiction, 2016(1), 1–7. https://doi.org/10.1155/2016/7620860

17.

Cloud

Granfield

(2001). Natural recovery from substance dependency: Lessons for treatment providers. Journal of Social Work Practice in the Addictions, 1(1), 83–104. https://doi.org/10.1300/J160v01n01_07

18.

Cloud

Granfield

(2008). Conceptualizing recovery capital: Expansion of a theoretical construct. Substance Use & Misuse, 43(12-13), 1971–1986. https://doi.org/10.1080/10826080802289762

19.

Connery

H. S.

(2015). Medication-assisted treatment of opioid use disorder: Review of the evidence and future directions. Harvard Review of Psychiatry, 23(2), 63–75. https://doi.org/10.1097/HRP.0000000000000075

20.

Conversano

Rotondo

Lensi

Della Vista

Arpone

Reda

(2010). Optimism and its impact on mental and physical well-being. Clinical Practice and Epidemiology in Mental Health, 6(1), 25–29. https://doi.org/10.2174/1745017901006010025

21.

Corrigan

P. W.

Giffort

Rashid

Leary

Okeke

(1999). Recovery as a psychological construct. Community Mental Health Journal, 35(3), 231–239. https://doi.org/10.1023/A:1018741302682

22.

Cremer

L. J.

Board

Guy

Schieber

Asher

Parker

E. M.

(2021). Trends in pharmacy-based dispensing of Buprenorphine, extended-release Naltrexone, and Naloxone during the COVID-19 pandemic by age and sex – United States, March 2019 – December 2020. Drug and Alcohol Dependence, 232(1), Article 109192. https://doi.org/10.1016/j.drugalcdep.2021.109192

23.

Denomme

W. J.

Benhanoh

(2017). Helping concerned family members of individuals with substance use and concurrent disorders: An evaluation of a family member-oriented treatment program. Journal of Substance Abuse Treatment, 79(1), 34–45. https://doi.org/10.1016/j.jsat.2017.05.012

24.

Drake

R. E.

Whitley

(2014). Recovery and severe mental illness: Description and analysis. Canadian Journal of Psychiatry, 59(5), 236–242. https://doi.org/10.1177/070674371405900502

25.

el-Guebaly

(2012). The meanings of recovery from addiction: Evolution and promises. Journal of Addiction Medicine, 6(1), 1–9. https://doi.org/10.1097/ADM.0b013e31823ae540

26.

Elswick

Fallin-Bennett

Ashford

Werner-Wilson

(2018). Emerging adults and recovery capital: Barriers and facilitators to recovery. Journal of Addictions Nursing, 29(2), 78–83. https://doi.org/10.1097/JAN.0000000000000218

27.

Fishman

Wenzel

Scodes

Pavlicova

Lee

J. D.

Rotrosen

Nunes

(2020). Young adults have worse outcomes than older adults: Secondary analysis of a medication trial for opioid use disorder. Journal of Adolescent Health, 67(6), 778–785. https://doi.org/10.1016/j.jadohealth.2020.07.038

28.

Fishman

Wenzel

Wildberger

Burgower

(2020). A pilot randomized controlled trial of assertive treatment including family involvement and home delivery of medication for young adults with opioid use disorder. Addiction, 116(3), 548–557. https://doi.org/10.1111/add.15181

29.

Fishman

M. J.

Winstanley

E. L.

Curran

Garrett

Subramaniam

(2010). Treatment of opioid dependence in adolescents and young adults with extended release naltrexone: Preliminary case-series and feasibility. Addiction, 105(9), 1669–1676. https://doi.org/10.1111/j.1360-0443.2010.03015.x

30.

Gonzales

Anglin

M. D.

Beattie

Ong

C. A.

Glik

D. C.

(2012a). Perceptions of chronicity and recovery among youth in treatment for substance use problems. Journal of Adolescent Health, 51(2), 144–149. https://doi.org/10.1016/j.jadohealth.2011.11.010

31.

Gonzales

Anglin

M. D.

Beattie

Ong

C. A.

Glik

D. C.

(2012b). Understanding recovery barriers: Youth perceptions about substance use relapse. American Journal of Health Behavior, 36(5), 602–614. https://doi.org/10.5993/AJHB.36.5.3

32.

Gonzales

Hernandez

Douglas

S. B.

C. H.

(2015). Exploring the factor structure of a recovery assessment measure among substance-abusing youth. Journal of Psychoactive Drugs, 47(3), 187–196. https://doi.org/10.1080/02791072.2015.1053556

33.

Granfield

Cloud

(1999). Coming clean: Overcoming addiction without treatment. NYU Press. https://doi.org/10.2307/2654369

34.

Granfield

Cloud

(2001). Social context and “natural recovery”: The role of social capital in the resolution of drug-associated problems. Substance Use & Misuse, 36(11), 1543–1570. https://doi.org/10.1081/JA-100106963

35.

Hair

Black

W. C.

Babin

B. J.

Anderson

R. E.

(2010). Multivariate data analysis (7th ed.). Pearson Educational International.

36.

Hayes

A. F.

(2017). Introduction to mediation, moderation, and conditional process analysis, second edition: A regression-based approach. Guilford Publications.

37.

Hennessy

E. A.

(2017). Recovery capital: A systematic review of the literature. Addiction Research and Theory, 25(5), 349–360. https://doi.org/10.1080/16066359.2017.1297990

38.

Hillios

J. S.

(2013). The influence of social recovery capital and stress on the health and well-being of individuals recovering from addiction [Ph.D., Boston College]. ProQuest Dissertations & Theses Global.

39.

Hogue

Becker

S. J.

Wenzel

Henderson

C. E.

Bobek

Levy

Fishman

(2022). Family involvement in treatment and recovery for substance use disorders among transition-age youth: Research bedrocks and opportunities. Journal of Substance Abuse Treatment, 129(1), Article 108402. https://doi.org/10.1016/j.jsat.2021.108402

40.

Jason

L. A.

Guerrero

Salomon-Amend

Stevens

Light

J. M.

Stoolmiller

(2021). Context matters: Home-level but not individual-level recovery social capital predicts residents’ relapse. American Journal of Community Psychology, 67(3-4), 392–404. https://doi.org/10.1002/ajcp.12481

41.

Laudet

A. B.

White

W. L.

(2008). Recovery capital as prospective predictor of sustained recovery, life satisfaction, and stress among former poly-substance users. Substance Use & Misuse, 43(1), 27–54. https://doi.org/10.1080/10826080701681473

42.

Leslie

D. L.

Milchak

Gastfriend

D. R.

Herschman

P. L.

Bixler

E. O.

Velott

D. L.

Meyer

R. E.

(2015). Effects of injectable extended‐release naltrexone (XR‐NTX) for opioid dependence on residential rehabilitation outcomes and early follow‐up. American Journal on Addictions, 24(3), 265–270. https://doi.org/10.1111/ajad.12182

43.

Liddle

H. A.

Dakof

Rowe

Mohamed

A. B.

Henderson

Foulkrod

Lucas

DiFrancesco

(2024). Multidimensional family therapy for justice-involved young adults with substance use disorders. The Journal of Behavioral Health Services & Research, 51(2), 250–263. https://doi.org/10.1007/s11414-023-09852-5

44.

Liddle

H. A.

Dakof

G. A.

Diamond

(1992). Adolescent substance abuse: Multidimensional family therapy in action. In Kaufman

Kaufmann

(Eds.), Family therapy of drug and alcohol abuse (2nd ed., pp. 120–171). Allyn & Bacon.

45.

Marsch

L. A.

Moore

S. K.

Borodovsky

J. T.

Solhkhah

Badger

G. J.

Semino

Jarrett

Condon

K. D.

Rossettie

Vincent

Hajizadeh

Ducat

(2016). A randomized controlled trial of buprenorphine taper duration among opioid-dependent adolescents and young adults. Addiction, 111(8), 1406–1415. https://doi.org/10.1111/add.13363

46.

Matson

S. C.

Hobson

Abdel-Rasoul

Bonny

A. E.

(2014). A retrospective study of retention of opioid-dependent adolescents and young adults in an outpatient buprenorphine/naloxone clinic. Journal of Addiction Medicine, 8(3), 176–182. https://doi.org/10.1097/ADM.0000000000000035

47.

Mawson

Best

Beckwith

Dingle

G. A.

Lubman

D. I.

(2015). Social identity, social networks and recovery capital in emerging adulthood: A pilot study. Substance Abuse Treatment, Prevention, and Policy, 10(1), 45. https://doi.org/10.1186/s13011-015-0041-2

48.

McHugh

R. K.

Murray

H. W.

Hearon

B. A.

Pratt

E. M.

Pollack

M. H.

Safren

S. A.

Otto

M. W.

(2013). Predictors of dropout from psychosocial treatment in opioid-dependent outpatients: Predictors of treatment dropout. American Journal on Addictions, 22(1), 18–22. https://doi.org/10.1111/j.1521-0391.2013.00317.x

49.

Mitchell

S. G.

Monico

L. B.

Gryczynski

Fishman

M. J.

O'Grady

K. E.

Schwartz

R. P.

(2021). Extended-release naltrexone for youth with opioid use disorder. Journal of Substance Abuse Treatment, 130(1), Article 108407. https://doi.org/10.1016/j.jsat.2021.108407

50.

Moos

R. H.

Moos

B. S.

(2007). Protective resources and long-term recovery from alcohol use disorders. Drug and Alcohol Dependence, 86(1), 46–54. https://doi.org/10.1016/j.drugalcdep.2006.04.015

51.

Morgan

J. R.

Schackman

B. R.

Leff

J. A.

Linas

B. P.

Walley

A. Y.

(2018). Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population. Journal of Substance Abuse Treatment, 85(1), 90–96. https://doi.org/10.1016/j.jsat.2017.07.001

52.

Neale

Brown

(2016). ‘We are always in some form of contact’: Friendships among homeless drug and alcohol users living in hostels. Health and Social Care in the Community, 24(5), 557–566. https://doi.org/10.1111/hsc.12215

53.

Neale

Nettleton

Pickering

(2014). Gender sameness and difference in recovery from heroin dependence: A qualitative exploration. International Journal of Drug Policy, 25(1), 3–12. https://doi.org/10.1016/j.drugpo.2013.08.002

54.

Öcal

E. E.

Demirtaş

Atalay

B. I.

Önsüz

M. F.

Işıklı

Metintaş

Yenilmez

Ç.

(2022). Relationship between mental disorders and optimism in a community-based sample of adults. Behavioral Sciences, 12(2), 52. https://doi.org/10.3390/bs12020052

55.

Orford

(1994). Empowering family and friends: A new approach to the secondary prevention of addiction. Drug and Alcohol Review, 13(4), 417–429. https://doi.org/10.1080/09595239400185551

56.

Pilarinos

Bromberg

D. J.

Karamouzian

(2022). Access to medications for opioid use disorder and associated factors among adolescents and young adults: A systematic review. JAMA Pediatrics, 176(3), 304–311. https://doi.org/10.1001/jamapediatrics.2021.4606

57.

Quanbeck

Chih

M. Y.

Isham

Gustafson

(2014). Mobile delivery of treatment for alcohol use disorders: A review of the literature. Alcohol Research: Current Reviews, 36(1), 111–122. 26259005

58.

Rössler

(2016). The stigma of mental disorders: A millennia‐long history of social exclusion and prejudices. EMBO Reports, 17(9), 1250–1253. https://doi.org/10.15252/embr.201643041

59.

Rowe

C. L.

(2012). Family therapy for drug abuse: Review and updates 2003-2010. Journal of Marital and Family Therapy, 38(1), 59–81. https://doi.org/10.1111/j.1752-0606.2011.00280.x

60.

Rozenberg

(2020). The use of naltrexone among young adults with opioid use disorder (2020-51430-176; Issues 12-B) [Doctoral Dissertation, University of Maryland]. ProQuest Information & Learning. https://ezproxy.shsu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=psyh&AN=2020-51430-176&site=ehost-live&scope=site

61.

Schuman-Olivier

Weiss

R. D.

Hoeppner

B. B.

Borodovsky

Albanese

M. J.

(2014). Emerging adult age status predicts poor buprenorphine treatment retention. Journal of Substance Abuse Treatment, 47(3), 202–212. https://doi.org/10.1016/j.jsat.2014.04.006

62.

Sheidow

A. J.

McCart

M. R.

Davis

(2016). Multisystemic therapy for emerging adults with serious mental illness and justice involvement. Cognitive and Behavioral Practice, 23(3), 356–367. https://doi.org/10.1016/j.cbpra.2015.09.003

63.

Silverstein

Hadland

S. E.

Hallett

Botticelli

(2021). Principles of care for young adults with substance use disorders. Pediatrics, 147(Suppl 2), S195–S203. https://doi.org/10.1542/peds.2020-023523B

64.

Smyth

B. P.

Barry

Keenan

Ducray

(2010). Lapse and relapse following inpatient treatment of opiate dependence. Irish Medical Journal, 103(6), 176–179. 20669601

65.

Sobell

L. C.

Sobell

M. B.

(1996). Timeline followback: User’s guide. Addiction Research Foundation.

66.

Stacy

M. A.

Rosenheck

(2019). The association of recovery orientation and stigmatizing beliefs. Journal of Mental Health, 28(3), 276–281. https://doi.org/10.1080/09638237.2017.1417573

67.

Suba

Lieberman

Davis

(2018). Medication-assisted treatment for opioid use disorder: The gold standard. National Health Law Program. https://healthlaw.org/wp-content/uploads/2018/05/MAT-IB-Final-51718-1.pdf

68.

Substance Abuse and Mental Health Services Administration . (2012). SAMHSA’s working definition of recovery: 10 guiding principles of recovery [Brochure].

69.

Substance Abuse and Mental Health Services Administration . (2021). Key substance use and mental health indicators in the United States: Results from the 2020 national survey on drug use and health. https://www.samhsa.gov/data/sites/default/files/reports/rpt39443/2021NSDUHFFRRev010323.pdf

70.

Substance Abuse and Mental Health Services Administration . (2023). Results from the 2022 national survey on drug use and health: Graphics from the key findings report. https://www.samhsa.gov/data/sites/default/files/reports/rpt42731/2022-nnr-briefing-slides.pdf

71.

Tambling

R. R.

Russell

D’Aniello

(2022). Where is the family in young adult substance use treatment? The case for systemic family therapy for young adults with substance use disorders. International Journal of Mental Health and Addiction, 20(3), 1659–1670. https://doi.org/10.1007/s11469-020-00471-1

72.

Tanner-Smith

E. E.

Wilson

S. J.

Lipsey

M. W.

(2013). The comparative effectiveness of outpatient treatment for adolescent substance abuse: A meta-analysis. Journal of Substance Abuse Treatment, 44(2), 145–158. https://doi.org/10.1016/j.jsat.2012.05.006

73.

Termorshuizen

Krol

Prins

Geskus

van den Brink

van Ameijden

E. J. C.

(2005). Prediction of relapse to frequent heroin use and the role of methadone prescription: An analysis of the Amsterdam Cohort Study among drug users. Drug and Alcohol Dependence, 79(2), 231–240. https://doi.org/10.1016/j.drugalcdep.2005.01.013

74.

Terrion

J. L.

(2013). The experience of post-secondary education for students in recovery from addiction to drugs or alcohol: Relationships and recovery capital. Journal of Social and Personal Relationships, 30(1), 3–23. https://doi.org/10.1177/0265407512448276

75.

Ventura

A. S.

Bagley

S. M.

(2017). To improve substance use disorder prevention, treatment and recovery: Engage the family. Journal of Addiction Medicine, 11(5), 339–341. https://doi.org/10.1097/ADM.0000000000000331

76.

Viera

Bromberg

D. J.

Whittaker

Refsland

B. M.

Stanojlović

Nyhan

Altice

F. L.

(2020). Adherence to and retention in medications for opioid use disorder among adolescents and young adults. Epidemiologic Reviews, 42(1), 41–56. https://doi.org/10.1093/epirev/mxaa001

77.

Volkow

N. D.

Jones

E. B.

Einstein

E. B.

Wargo

E. M.

(2019). Prevention and treatment of opioid misuse and addiction: A review. JAMA Psychiatry, 76(2), 208–216. https://doi.org/10.1001/jamapsychiatry.2018.3126

78.

Wenzel

Fishman

(2021). Mobile van delivery of extended-release buprenorphine and extended-release naltrexone for youth with OUD: An adaptation to the COVID-19 emergency. Journal of Substance Abuse Treatment, 120(1), Article 108149. https://doi.org/10.1016/j.jsat.2020.108149

79.

Wenzel

Fishman

Wildberger

Burgower

(2020). An assertive outreach intervention for treatment of opioid use disorder in young adults. Heroin Addiction and Related Clinical Problems, 23(4), 51–58.

80.

Wenzel

Selby

Wildberger

Lavorato

Thomas

Fishman

(2021). Choice of extended release medication for OUD in young adults (buprenorphine or naltrexone): A pilot enhancement of the youth opioid recovery support (YORS) intervention. Journal of Substance Abuse Treatment, 125(1), Article 108306. https://doi.org/10.1016/j.jsat.2021.108306

81.

White

W. L.

(2007). Addiction recovery: Its definition and conceptual boundaries. Journal of Substance Abuse Treatment, 33(3), 229–241. https://doi.org/10.1016/j.jsat.2007.04.015

82.

White

W. L.

Cloud

(2008). Recovery capital: A primer for addictions professionals. Counselor, 9(5), 22–27. https://static1.squarespace.com/static/5e8cca3f54b123010e2d5787/t/602d03f55f9f9002e0c73686/1613562869199/Recovery+Capital+-+A+Primer+for+Professionals+%28White+and+Cloud%2C+2008%29.pdf.

83.

Whitfield

J. B.

Zhu

Landers

J. G.

Martin

N. G.

(2020). Pessimism is associated with greater all-cause and cardiovascular mortality, but optimism is not protective. Scientific Reports, 10(1), Article 12609. https://doi.org/10.1038/s41598-020-69388-y

84.

Wood

L. L.

(2020, August). “Everything I did in addiction, I’m pretty much the opposite now”: Recovery capital and pathways to recovery from opiate addiction [M.A., Kent state university]. ProQuest Dissertations & Theses Global. https://www.proquest.com/docview/2440882766/abstract/741A425E512448F2PQ/1

85.

Yule

A. M.

Lyons

R. M.

Wilens

T. E.

(2018). Opioid use disorders in adolescents—updates in assessment and management. Current Pediatrics Reports, 6(2), 99–106. https://doi.org/10.1007/s40124-018-0161-z

86.

Zhang

Feng

Geng

Owens

(2016). “Overconfidence” versus “helplessness”: A qualitative study on abstinence self-efficacy of drug users in a male compulsory drug detention center in China. Substance Abuse Treatment, Prevention, and Policy, 11(1), 29. https://doi.org/10.1186/s13011-016-0073-2

Impact of Relationship Quality and Recovery Attitudes on Medication for Opioid Use Disorder Among Young Adults

Abstract

Keywords

Get full access to this article

References